• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌分级方法的预后价值——一项方法比较研究。

Prognostic value of ovarian carcinoma grading methods--a method comparison study.

作者信息

Haapasalo H, Collan Y, Seppä A, Gidlund A L, Atkin N B, Pesonen E

机构信息

Department of Pathology, University of Kuopio, Finland.

出版信息

Histopathology. 1990 Jan;16(1):1-7. doi: 10.1111/j.1365-2559.1990.tb01053.x.

DOI:10.1111/j.1365-2559.1990.tb01053.x
PMID:2407634
Abstract

The prognostic value of subjective histological and morphometric grading was studied in 75 primary ovarian carcinomas. Histological grading methods recommended by Czernobilsky and by Russell and the morphometric method of Baak and co-workers were compared in a two-observer system. The 5-year survival could be correctly predicted in about two-thirds of the patients with all three methods. When mitotic counting (volume corrected mitotic index, M/V-index) was compared with the above grading methods by using a receiver operating characteristic curve) the M/V-index was generally superior in its prognostic power regardless of the sensitivity/specificity level chosen. The morphometric grading method and the grading method based on the M/V index were also shown to be readily reproducible.

摘要

对75例原发性卵巢癌患者研究了主观组织学和形态计量学分级的预后价值。在双观察者系统中比较了Czernobilsky、Russell推荐的组织学分级方法以及Baak及其同事的形态计量学方法。使用这三种方法,约三分之二的患者的5年生存率能够得到正确预测。当通过绘制受试者工作特征曲线将有丝分裂计数(体积校正有丝分裂指数,M/V指数)与上述分级方法进行比较时,无论选择何种灵敏度/特异性水平,M/V指数在预后能力方面总体上更具优势。形态计量学分级方法和基于M/V指数的分级方法也显示出易于重复。

相似文献

1
Prognostic value of ovarian carcinoma grading methods--a method comparison study.卵巢癌分级方法的预后价值——一项方法比较研究。
Histopathology. 1990 Jan;16(1):1-7. doi: 10.1111/j.1365-2559.1990.tb01053.x.
2
Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients.
Anal Quant Cytol Histol. 1987 Aug;9(4):287-90.
3
Prognosis of ovarian carcinomas: prediction by histoquantitative methods.卵巢癌的预后:通过组织定量方法进行预测
Histopathology. 1989 Aug;15(2):167-78. doi: 10.1111/j.1365-2559.1989.tb03064.x.
4
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
Int J Cancer. 1993 Oct 21;55(4):547-54. doi: 10.1002/ijc.2910550405.
5
Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study.有丝分裂计数在乳腺癌预后评估及分级中的应用。方法评估研究。
Pathol Res Pract. 1994 Jun;190(6):593-9. doi: 10.1016/S0344-0338(11)80397-3.
6
Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.迈向卵巢上皮性癌通用分级系统的发展。I. 组织病理学特征的预后意义——结构分级系统中存在的问题。
Gynecol Oncol. 1998 Jul;70(1):2-12. doi: 10.1006/gyno.1998.5051.
7
Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours.用于评估卵巢肿瘤预后的与国际妇产科联盟(FIGO)分期、组织学类型及分级相关的形态学数据。
J Clin Pathol. 1986 Dec;39(12):1340-6. doi: 10.1136/jcp.39.12.1340.
8
Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.卵巢癌的肿瘤倍体、形态测定、组织学分级及临床特征:相互关系
Anal Cell Pathol. 1991 Sep;3(5):261-71.
9
Consistency of quantitative methods in ovarian tumor histopathology.
Int J Gynecol Pathol. 1990;9(3):208-16. doi: 10.1097/00004347-199007000-00002.
10
Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.猫乳腺癌组织学分级的预后价值:一项回顾性生存分析
Vet Pathol. 2015 Mar;52(2):238-49. doi: 10.1177/0300985814543198. Epub 2014 Jul 24.

引用本文的文献

1
Cancer stem cells and field cancerization of head and neck cancer - An update.头颈部癌的癌症干细胞与场癌化——最新进展
J Family Med Prim Care. 2020 Jul 30;9(7):3178-3182. doi: 10.4103/jfmpc.jfmpc_443_20. eCollection 2020 Jul.
2
Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma.TNM分期为T1期的卵巢透明细胞腺癌患者中细胞核形态测量的预后价值。
Br J Cancer. 1999 Apr;79(11-12):1736-41. doi: 10.1038/sj.bjc.6690276.
3
Proliferation markers in tumours: interpretation and clinical value.
肿瘤中的增殖标志物:解读与临床价值。
J Clin Pathol. 1998 Oct;51(10):716-24. doi: 10.1136/jcp.51.10.716.
4
Nuclear grading of renal cell carcinomas--is morphometry necessary?肾细胞癌的核分级——形态测量学是否必要?
J Cancer Res Clin Oncol. 1991;117(1):73-8. doi: 10.1007/BF01613201.
5
Laboratory handling of impalpable breast lesions: a review.不可触及乳腺病变的实验室处理:综述
J Clin Pathol. 1991 Feb;44(2):89-93. doi: 10.1136/jcp.44.2.89.
6
Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.乳腺癌筛查中的病理报告。皇家病理学家学会工作组。
J Clin Pathol. 1991 Sep;44(9):710-25. doi: 10.1136/jcp.44.9.710.